Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInventory AverageNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Sales

CollPlant Biotechnologies (CLGN) Return on Capital Employed (2018 - 2025)

Historic Return on Capital Employed for CollPlant Biotechnologies (CLGN) over the last 8 years, with Q3 2025 value amounting to 0.2%.

  • CollPlant Biotechnologies' Return on Capital Employed fell 1200.0% to 0.2% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.2%, marking a year-over-year decrease of 1200.0%. This contributed to the annual value of 0.74% for FY2024, which is 5100.0% down from last year.
  • Latest data reveals that CollPlant Biotechnologies reported Return on Capital Employed of 0.2% as of Q3 2025, which was down 1200.0% from 0.62% recorded in Q2 2025.
  • Over the past 5 years, CollPlant Biotechnologies' Return on Capital Employed peaked at 355.49% during Q1 2021, and registered a low of 0.62% during Q2 2025.
  • Over the past 5 years, CollPlant Biotechnologies' median Return on Capital Employed value was 0.09% (recorded in 2024), while the average stood at 20.15%.
  • As far as peak fluctuations go, CollPlant Biotechnologies' Return on Capital Employed skyrocketed by 3559600bps in 2021, and later crashed by -3556200bps in 2022.
  • CollPlant Biotechnologies' Return on Capital Employed (Quarter) stood at 0.0% in 2021, then tumbled by -20257bps to 0.27% in 2022, then skyrocketed by 87bps to 0.03% in 2023, then skyrocketed by 200bps to 0.03% in 2024, then tumbled by -691bps to 0.2% in 2025.
  • Its last three reported values are 0.2% in Q3 2025, 0.62% for Q2 2025, and 0.37% during Q1 2025.